These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18571641)

  • 21. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.
    Günther L; Rothe J; Rex A; Voigt JP; Millan MJ; Fink H; Bert B
    Neuropharmacology; 2011 Sep; 61(3):433-41. PubMed ID: 21419787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.
    Wong EH; Sonders MS; Amara SG; Tinholt PM; Piercey MF; Hoffmann WP; Hyslop DK; Franklin S; Porsolt RD; Bonsignori A; Carfagna N; McArthur RA
    Biol Psychiatry; 2000 May; 47(9):818-29. PubMed ID: 10812041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
    Rogóz Z; Skuza G
    Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezing.
    Inoue T; Nakagawa S; Izumi T; Kitaichi Y; Koyama T
    Eur J Pharmacol; 2006 Jul; 540(1-3):91-5. PubMed ID: 16714013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant-induced undesirable weight gain: prevention with rimonabant without interference with behavioral effectiveness.
    Gobshtis N; Ben-Shabat S; Fride E
    Eur J Pharmacol; 2007 Jan; 554(2-3):155-63. PubMed ID: 17116301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
    Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test.
    Kang S; Kim HJ; Kim HJ; Shin SK; Choi SH; Lee MS; Shin KH
    Eur J Pharmacol; 2010 Nov; 647(1-3):110-6. PubMed ID: 20826136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
    Leggio GM; Micale V; Drago F
    Eur Neuropsychopharmacol; 2008 Apr; 18(4):271-7. PubMed ID: 17804207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M
    J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice.
    Wesołowska A; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E
    Eur J Pharmacol; 2007 Jan; 555(1):43-7. PubMed ID: 17109856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects.
    Munari L; Provensi G; Passani MB; Galeotti N; Cassano T; Benetti F; Corradetti R; Blandina P
    Int J Neuropsychopharmacol; 2015 Apr; 18(10):pyv045. PubMed ID: 25899065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.
    Gannon RL; Millan MJ
    Psychopharmacology (Berl); 2007 Dec; 195(3):325-32. PubMed ID: 17694388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.
    Connor TJ; Kelliher P; Harkin A; Kelly JP; Leonard BE
    Eur J Pharmacol; 1999 Aug; 379(2-3):125-33. PubMed ID: 10497898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system.
    Nixon MK; Hascoet M; Bourin M; Colombel MC
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):59-64. PubMed ID: 7862913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action.
    Dutta AK; Ghosh B; Biswas S; Reith ME
    Eur J Pharmacol; 2008 Jul; 589(1-3):73-9. PubMed ID: 18561912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
    Filip M; Wydra K; Inan SY; Dziedzicka-Wasylewska M; Przegaliński E
    Eur J Pharmacol; 2004 Sep; 498(1-3):143-51. PubMed ID: 15363988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression?
    Prica C; Hascoet M; Bourin M
    Behav Brain Res; 2008 Dec; 194(1):92-9. PubMed ID: 18647622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The norepinephrine reuptake inhibitor reboxetine is more potent in treating murine narcoleptic episodes than the serotonin reuptake inhibitor escitalopram.
    Schmidt C; Leibiger J; Fendt M
    Behav Brain Res; 2016 Jul; 308():205-10. PubMed ID: 27118715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological interaction with the sigma1 (σ1)-receptor in the acute behavioral effects of antidepressants.
    Villard V; Meunier J; Chevallier N; Maurice T
    J Pharmacol Sci; 2011; 115(3):279-92. PubMed ID: 21427517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.